Hello Heart, a heart health digital therapeutics solution, completed a $45 million Series C funding round led by IVP. It plans to use the funding to hire new team members and expand its Hello Heart cardiac monitoring application to include additional clinical heart heath offerings.
IVP is a top later-stage partner for hypergrowth companies including Coinbase, Lyra Health, Slack, Snap, Twitter, and UiPath, and is one of the strongest growth funds in the world with more than 120 IPOs. Hello Heart’s existing investors, including Khosla Ventures, BlueRun Ventures, Maven Ventures, and Resolute Ventures also participated in the round. In conjunction with the financing, Somesh Dash, general partner at IVP, will join Hello Heart’s Board of Directors.
Hello Heart’s mission is to empower people to manage and improve their heart health using digital technology. The company’s flagship solution helps people manage their blood pressure, pulse, medications, and activity using artificial intelligence (AI)-based technology. Users track key health metrics, receive personalized feedback, and take steps to improve their health with clinically proven suggestions, all through the convenience of their smartphone. Hello Heart’s solution enables users to quickly identify a hypertensive crisis or irregular heartbeat, facilitating a timely referral to their doctor to treat and prevent a potentially catastrophic cardiac event.
The company was founded in 2013; it has tripled its business over the last year, with its program being offered by large enterprise companies, including many Fortune 500 employers, as part of their benefits programs. Its product has been recognized for hypertension management by the American Heart Association and, after a thorough clinical and security review, CVS Health added Hello Heart to its prestigious Point Solutions Management platform. In a retrospective peer-reviewed study performed by researchers from UCLA and Harvard Medical School, 70% of users reduced their blood pressure and the average decrease of systolic blood pressure was 22 mmHg. These clinical results are over 2x higher than any other results published in a peer-reviewed, clinical study.
This was reported by Hello Heart on May 26, 2021.
Contact information: Hello Heart, Inc., 333 Bradford St., Ste 150, Redwood City, CA 94063-1572; 800-767-3471; Website: https://www.helloheart.com/